4.2 Article

Novel ANKH Mutation in a Patient With Sporadic Craniometaphyseal Dysplasia

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 152A, Issue 3, Pages 770-776

Publisher

WILEY
DOI: 10.1002/ajmg.a.33317

Keywords

craniometaphyseal dysplasia; ANKH; deletion mutation; intracellular protein trafficking

Funding

  1. NIH/NIAMS [AR50627]

Ask authors/readers for more resources

Craniometaphyseal dysplasia is caused by mutations in ANKH(ankylosis, progressive homolog [mouse]) in the majority of cases, and all of the reported mutations are single amino acid changes. Genomic DNA from an affected patient, his biological parents, and a sibling was amplified and ANKH was sequenced. The affected patient had a complex heterozygous mutation in exon 7 (c.936T > C, c.938C > G, c.942_953delTGGTTGACGGAA), predicting p.Try290Gln and p.Trp292_Glu295del. We studied the effect of the predicted mutation on the subcellular distribution of ANKH protein. Immunofluorescent labeling of COS-7 cells transduced with normal or mutant Ank (murine progressive ankylosis), showed that normal Ank localized to both the plasma membrane and cytoplasm, whereas mutant Ank was detected only in the cytoplasmic compartment. We propose that this craniometaphyseal dysplasia mutation causes a loss of ANKH protein expression and activity in the plasma membrane as a result of aberrant intracellular protein trafficking. (C) 2010 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available